IMR fundamentals
An in-depth look to AC IMMUNE SA SF-,02 operating, investing, and financing activities
IMR free cash flow for Q1 24 is 821.47 k EUR. For 2023, IMR free cash flow was -61.71 M EUR and operating cash flow was -60.9 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM